BALCAO · LESSORS OF REAL PROPERTY, NEC · SMALL CAP
Regional Health Properties, Inc. RHEP
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$53.2M
▲ 189.9% vs FY2024
EPS · FY25
$1.09
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
6.3%
Dividend coverage
-4.5×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 53.2M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
6 cents of every revenue dollar became profit this year.
Per share
USD 1.09
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
—
Return on equity, FY2025
ROE
Operating margin3.1%
Net margin6.3%
Return on assets5.3%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+24.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+14.0%
+24.8%
+11.2%
+0.3%
Returned to shareholders
−24.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years+11.3%
Change, 10 years—
The share count grew 11% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 67.8M
total assets, end of FY2025
Total assetsUSD 67.8M
EquityUSD 349,000.00
CashUSD 3.0M
Gross debtUSD 40.2M
Net debtUSD 37.2M
Current ratio0.67×
Net debt stands at 10645% of equity.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.2
0.1
0.1
Operating income $B
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
EBITDA $B
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
−0.0
Income tax $B
0.0
·
·
·
·
·
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
1.09
−1.73
21.05
−8.93
−5.87
−5.74
−2.07
−11.86
−5.20
−0.74
−1.46
−0.90
−0.94
−0.50
−0.59
−0.38
Dividend / sh $
·
·
·
·
·
·
·
·
·
0.17
0.17
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
−0
−14
−0
·
·
·
·
ROE %
·
·
−199.3
−97.3
−11.0
−6.0
61.5
−99.0
·
·
·
−190.0
−103.1
−42.7
−40.6
−15.6
Shares out B
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.02
0.02
0.02
0.01
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
44 of 44
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed